Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 1 | 53 | 2026 | 866 | 8.910 |
Why?
|
| Blood Glucose Self-Monitoring | 35 | 2026 | 128 | 6.550 |
Why?
|
| Insulin Infusion Systems | 25 | 2026 | 66 | 5.260 |
Why?
|
| Blood Glucose | 35 | 2026 | 1104 | 5.230 |
Why?
|
| Hypoglycemia | 17 | 2026 | 181 | 4.080 |
Why?
|
| Hypoglycemic Agents | 30 | 2026 | 475 | 3.780 |
Why?
|
| Insulin | 25 | 2026 | 1151 | 3.290 |
Why?
|
| Diabetic Ketoacidosis | 7 | 2026 | 164 | 1.560 |
Why?
|
| Hyperglycemia | 6 | 2022 | 234 | 0.980 |
Why?
|
| Automobile Driving | 1 | 2025 | 29 | 0.870 |
Why?
|
| Wearable Electronic Devices | 3 | 2025 | 116 | 0.720 |
Why?
|
| Social Determinants of Health | 1 | 2023 | 162 | 0.700 |
Why?
|
| Adolescent | 33 | 2026 | 20931 | 0.690 |
Why?
|
| Child | 39 | 2026 | 26250 | 0.680 |
Why?
|
| Registries | 5 | 2021 | 1599 | 0.570 |
Why?
|
| Monitoring, Ambulatory | 4 | 2020 | 57 | 0.510 |
Why?
|
| Humans | 62 | 2026 | 131604 | 0.500 |
Why?
|
| Child, Preschool | 21 | 2025 | 15054 | 0.480 |
Why?
|
| Adipose Tissue | 2 | 2016 | 495 | 0.470 |
Why?
|
| Young Adult | 18 | 2025 | 10094 | 0.470 |
Why?
|
| Male | 39 | 2026 | 65228 | 0.450 |
Why?
|
| Female | 41 | 2026 | 71145 | 0.440 |
Why?
|
| Parents | 6 | 2020 | 1109 | 0.390 |
Why?
|
| Self-Management | 2 | 2025 | 117 | 0.390 |
Why?
|
| Adrenarche | 1 | 2013 | 11 | 0.390 |
Why?
|
| Puberty, Precocious | 1 | 2013 | 29 | 0.380 |
Why?
|
| Bone Development | 1 | 2013 | 55 | 0.380 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 2013 | 34 | 0.380 |
Why?
|
| Monitoring, Physiologic | 2 | 2016 | 371 | 0.370 |
Why?
|
| Telemedicine | 2 | 2021 | 519 | 0.360 |
Why?
|
| Diabetes Mellitus | 2 | 2022 | 890 | 0.320 |
Why?
|
| Adult | 22 | 2024 | 31702 | 0.310 |
Why?
|
| Curriculum | 2 | 2020 | 783 | 0.280 |
Why?
|
| Hypopituitarism | 1 | 2008 | 19 | 0.280 |
Why?
|
| Caregivers | 2 | 2024 | 583 | 0.270 |
Why?
|
| Pilot Projects | 3 | 2025 | 1453 | 0.270 |
Why?
|
| Camping | 3 | 2016 | 14 | 0.260 |
Why?
|
| Health Status Disparities | 2 | 2021 | 278 | 0.250 |
Why?
|
| Cholestasis | 1 | 2008 | 165 | 0.240 |
Why?
|
| Prospective Studies | 6 | 2023 | 6494 | 0.210 |
Why?
|
| Treatment Outcome | 4 | 2026 | 12964 | 0.200 |
Why?
|
| Self Care | 1 | 2025 | 231 | 0.200 |
Why?
|
| Biosensing Techniques | 2 | 2014 | 75 | 0.200 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 79 | 0.200 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2019 | 501 | 0.190 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 3834 | 0.190 |
Why?
|
| Glucose | 3 | 2022 | 848 | 0.180 |
Why?
|
| Stress, Psychological | 2 | 2024 | 562 | 0.180 |
Why?
|
| Quality of Life | 4 | 2025 | 2113 | 0.180 |
Why?
|
| Internship and Residency | 1 | 2012 | 1215 | 0.180 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2021 | 18 | 0.180 |
Why?
|
| Off-Label Use | 1 | 2021 | 26 | 0.180 |
Why?
|
| Demography | 1 | 2021 | 243 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 1413 | 0.160 |
Why?
|
| Sodium | 1 | 2021 | 281 | 0.160 |
Why?
|
| Diabetic Retinopathy | 1 | 2021 | 84 | 0.160 |
Why?
|
| Technology | 1 | 2020 | 69 | 0.150 |
Why?
|
| Hypertrophy | 2 | 2016 | 101 | 0.140 |
Why?
|
| Feeding and Eating Disorders | 1 | 2019 | 74 | 0.140 |
Why?
|
| Medicare | 1 | 2021 | 437 | 0.140 |
Why?
|
| Cost of Illness | 1 | 2019 | 291 | 0.130 |
Why?
|
| Minority Groups | 1 | 2019 | 256 | 0.130 |
Why?
|
| Pancreas, Artificial | 1 | 2016 | 2 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 324 | 0.130 |
Why?
|
| Clinical Alarms | 1 | 2016 | 9 | 0.130 |
Why?
|
| Glucagon | 1 | 2016 | 146 | 0.130 |
Why?
|
| United States | 6 | 2024 | 11800 | 0.120 |
Why?
|
| Quality Improvement | 1 | 2022 | 707 | 0.120 |
Why?
|
| Hormones | 1 | 2016 | 165 | 0.120 |
Why?
|
| Infusion Pumps, Implantable | 3 | 2020 | 35 | 0.120 |
Why?
|
| Fear | 1 | 2017 | 198 | 0.120 |
Why?
|
| Dyslipidemias | 1 | 2018 | 247 | 0.120 |
Why?
|
| Hospitalization | 1 | 2024 | 1939 | 0.110 |
Why?
|
| Acetaminophen | 1 | 2015 | 97 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 506 | 0.110 |
Why?
|
| Accelerometry | 2 | 2025 | 66 | 0.100 |
Why?
|
| Cell Phone | 1 | 2013 | 32 | 0.100 |
Why?
|
| Texas | 2 | 2021 | 3615 | 0.100 |
Why?
|
| Calibration | 1 | 2013 | 95 | 0.100 |
Why?
|
| Age Factors | 2 | 2018 | 2872 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2025 | 2986 | 0.100 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2013 | 22 | 0.100 |
Why?
|
| Cohort Studies | 4 | 2019 | 5123 | 0.100 |
Why?
|
| Retrospective Studies | 3 | 2026 | 17666 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2025 | 3094 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 2297 | 0.090 |
Why?
|
| Anxiety | 1 | 2019 | 1003 | 0.090 |
Why?
|
| Algorithms | 2 | 2016 | 1686 | 0.090 |
Why?
|
| Body Height | 1 | 2013 | 196 | 0.090 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 743 | 0.090 |
Why?
|
| Consensus | 2 | 2025 | 565 | 0.080 |
Why?
|
| Medical Errors | 1 | 2012 | 152 | 0.080 |
Why?
|
| Infant | 5 | 2025 | 13305 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2013 | 834 | 0.080 |
Why?
|
| Aged | 4 | 2024 | 21255 | 0.080 |
Why?
|
| Time Factors | 2 | 2018 | 6279 | 0.080 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 2010 | 20 | 0.080 |
Why?
|
| Hand Strength | 1 | 2010 | 59 | 0.080 |
Why?
|
| Range of Motion, Articular | 1 | 2010 | 84 | 0.080 |
Why?
|
| Decompression, Surgical | 1 | 2010 | 89 | 0.080 |
Why?
|
| Machine Learning | 2 | 2025 | 375 | 0.070 |
Why?
|
| Biomarkers | 1 | 2018 | 3405 | 0.070 |
Why?
|
| Electrocardiography | 2 | 2025 | 983 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 1255 | 0.070 |
Why?
|
| Inpatients | 1 | 2012 | 545 | 0.070 |
Why?
|
| Bile Ducts | 1 | 2008 | 53 | 0.070 |
Why?
|
| Growth Hormone | 1 | 2008 | 127 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 902 | 0.060 |
Why?
|
| Body Mass Index | 1 | 2013 | 1695 | 0.060 |
Why?
|
| Risk Factors | 3 | 2025 | 10959 | 0.060 |
Why?
|
| Equipment Failure | 2 | 2016 | 128 | 0.060 |
Why?
|
| Photoplethysmography | 1 | 2025 | 9 | 0.060 |
Why?
|
| Socioeconomic Factors | 2 | 2021 | 897 | 0.060 |
Why?
|
| Qualitative Research | 2 | 2019 | 706 | 0.060 |
Why?
|
| Southwestern United States | 1 | 2025 | 45 | 0.060 |
Why?
|
| Cross-Over Studies | 2 | 2016 | 331 | 0.060 |
Why?
|
| Pandemics | 2 | 2024 | 1161 | 0.060 |
Why?
|
| Protective Factors | 1 | 2025 | 93 | 0.060 |
Why?
|
| Patient Satisfaction | 2 | 2023 | 459 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2025 | 4039 | 0.050 |
Why?
|
| Circadian Rhythm | 2 | 2017 | 315 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2022 | 12 | 0.050 |
Why?
|
| Pediatrics | 1 | 2012 | 1231 | 0.050 |
Why?
|
| Middle Aged | 5 | 2024 | 28883 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 300 | 0.040 |
Why?
|
| Baltimore | 1 | 2021 | 43 | 0.040 |
Why?
|
| Recurrence | 1 | 2025 | 1483 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2023 | 221 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1516 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2025 | 794 | 0.040 |
Why?
|
| Austria | 1 | 2019 | 21 | 0.040 |
Why?
|
| Germany | 1 | 2019 | 55 | 0.040 |
Why?
|
| Psychotherapy | 1 | 2022 | 245 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 322 | 0.040 |
Why?
|
| Developed Countries | 1 | 2019 | 44 | 0.040 |
Why?
|
| Self Report | 1 | 2022 | 558 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2025 | 8588 | 0.040 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2019 | 27 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2023 | 5296 | 0.040 |
Why?
|
| Mobile Applications | 1 | 2020 | 114 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2020 | 394 | 0.040 |
Why?
|
| Age of Onset | 1 | 2020 | 632 | 0.040 |
Why?
|
| Longevity | 1 | 2019 | 176 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2019 | 440 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2019 | 251 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2020 | 317 | 0.030 |
Why?
|
| Linear Models | 1 | 2019 | 695 | 0.030 |
Why?
|
| Triglycerides | 1 | 2020 | 605 | 0.030 |
Why?
|
| Emigrants and Immigrants | 1 | 2019 | 169 | 0.030 |
Why?
|
| Bionics | 1 | 2016 | 2 | 0.030 |
Why?
|
| Learning | 1 | 2020 | 369 | 0.030 |
Why?
|
| Nausea | 1 | 2016 | 83 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 612 | 0.030 |
Why?
|
| Health Planning Guidelines | 1 | 2016 | 33 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2017 | 282 | 0.030 |
Why?
|
| Parenting | 1 | 2019 | 349 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1346 | 0.030 |
Why?
|
| Patient Preference | 1 | 2017 | 146 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2015 | 156 | 0.030 |
Why?
|
| Decision Making | 1 | 2020 | 683 | 0.030 |
Why?
|
| Research | 1 | 2016 | 266 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2014 | 61 | 0.030 |
Why?
|
| Automation | 1 | 2014 | 67 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2694 | 0.030 |
Why?
|
| Outpatients | 1 | 2015 | 266 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2143 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 4952 | 0.020 |
Why?
|
| Depression | 1 | 2019 | 1338 | 0.020 |
Why?
|
| Probability | 1 | 2010 | 310 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 432 | 0.020 |
Why?
|
| Physical Examination | 1 | 2010 | 169 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2010 | 354 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 456 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2010 | 409 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 6922 | 0.010 |
Why?
|